Andrew M. Tonkin

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

John W. Eikelboom, Stuart J. Connolly, Jackie Bosch et al. · New England Journal of Medicine · 2017 · 2.3K citations · Full text

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

Paul Moayyedi, John W. Eikelboom, Jackie Bosch et al. · Gastroenterology · 2019 · 469 citations · Full text

Drug Safety, Patient Safety, Pharmacology +6

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

Paul Moayyedi, John W. Eikelboom, Jackie Bosch et al. · Gastroenterology · 2019 · 149 citations · Full text

Drug Safety, Prevent Gastroduodenal Events, Rivaroxaban And/or Aspirin +9

Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease

Deepak L. Bhatt, John W. Eikelboom, Stuart J. Connolly et al. · Circulation · 2020 · 147 citations · Full text

Long-term risk stratification for survivors of acute coronary syndromes

Ian C. Marschner, David Colquhoun, R. J. Simes et al. · Journal of the American College of Cardiology · 2001 · 130 citations

Cardiovascular Epidemiology, Cardiovascular Disease, Long-term Risk Stratification +6